Steven McAllister

2015

In 2015, Steven McAllister earned a total compensation of $843.6K as Chief Financial Officer at InVivo Therapeutics Holdings, a 19% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$99,750
Option Awards$452,319
Salary$277,992
Other$13,531
Total$843,592

McAllister received $452.3K in option awards, accounting for 54% of the total pay in 2015.

McAllister also received $99.8K in non-equity incentive plan, $278K in salary and $13.5K in other compensation.

Rankings

In 2015, Steven McAllister's compensation ranked 8,753rd out of 13,638 executives tracked by ExecPay. In other words, McAllister earned more than 35.8% of executives.

ClassificationRankingPercentile
All
8,753
out of 13,638
36th
Division
Manufacturing
3,345
out of 5,190
36th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
444
out of 760
42nd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
255
out of 466
45th
Industry
Surgical and Medical Instruments and Apparatus
145
out of 293
51st
Source: SEC filing on April 25, 2017.

McAllister's colleagues

We found five more compensation records of executives who worked with Steven McAllister at InVivo Therapeutics Holdings in 2015.

2015

Lorianne Masuoka

InVivo Therapeutics Holdings

Chief Medical Officer

2015

Mark Perrin

InVivo Therapeutics Holdings

Chief Executive Officer

2015

Thomas Ulich

InVivo Therapeutics Holdings

Chief Scientific Officer

2015

Tamara Joseph

InVivo Therapeutics Holdings

General Counsel

2015

Christopher McNulty

InVivo Therapeutics Holdings

Chief Financial Officer

In-depth

You may also like